Harold Keer

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer”.

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer

Cancer Medicine(2020)10.1002/cam4.3583

N/A

1.1DataRank · unranked

40 citations

Zeeshan Fazal, Ratnakar Singh, Emmanuel Bikorimana, Nabil Adra, Nasser H. Hanna +9 more

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.05.001

N/A

0.789DataRank · unranked

18 citations

Karen L. Reckamp, Paul Frankel, Jeff Longmate, Karen A. Kelly, David R. Gandara +7 more

CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3609

N/A

0.293DataRank · unranked

4 citations

James M. Cleary, Justine V. Cohen, Donald P. Lawrence, Elizabeth I. Buchbinder, Anita Giobbie‐Hurder +11 more

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood(2022)10.1182/blood.2022015832

N/A

0DataRank · unranked

36 citations

Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter +21 more